Alle persberichten

Generative AI Surpassing Human Abilities Finds Arthur D. Little Blue Shift Report

LONDON–(BUSINESS WIRE)– Arthur D. Little (ADL)’s Blue Shift Institute today published Generative Artificial Intelligence: Towards a New Civilization? a major new report on Artificial Intelligence...

EH Group test HTPEM-branstofcel om luchtvaart koolstofvrij te maken

NYON, Zwitserland–(BUSINESS WIRE)– EH Group heeft op succesvolle wijze haar unieke brandstofceltechnologie in hoge temperatuur PEM-modus (HTPEMFC) getest. De structuur van de cellen van EH...

Celltrion, Inc. en Celltrion Healthcare Co., Ltd. maken bekend dat de fusie van beide bedrijven is goedgekeurd door de aandeelhouders

Tijdens de buitengewone algemene vergadering van aandeelhouders op 23 oktober is de fusieovereenkomst tussen Celltrion, Inc. en Celltrion Healthcare Co., Ltd. goedgekeurd De raad van...

Alipay+ partners LankaPay to enhance digital travel experience to and from Sri Lanka

More than 400,000 merchants in Sri Lanka will be able to accept cross-border digital payments from some of Asia’s most popular digital payment apps, with...

LiveWire® Opens European Reservations for S2 Del Mar® and Confirms Pricing and Delivery Schedule

S2 Del Mar European pricing announced along with delivery schedule following recent Barcelona product introduction. MILWAUKEE–(BUSINESS WIRE)– LiveWire, the leading electric motorcycle manufacturer, is excited...

First results from PEGASUS trial reported at ESMO show promise for use of liquid biopsy to guide adjuvant treatment of colon cancer

Study results suggest Guardant RevealTM circulating tumor DNA blood test may help clinicians decide to pursue more or less aggressive post-surgical chemotherapy regimens PEGASUS is...

Genialis and Cancer Research Horizons Collaborate to Develop AI-Driven Patient Classifiers

Partnership provides high-quality and clinically relevant data for modeling and validation of novel biomarkers in UK patients BOSTON, LONDON & MADRID–(BUSINESS WIRE)– Genialis, the RNA-biomarker...

National Football League Teams Up with SES for Game Content Distribution

In a renewed partnership, SES’s hybrid distribution network to enable the NFL to reach over 35 partners in Europe, Asia and the Americas, deliver over...

Celltrion, Inc. & Celltrion Healthcare Co., Ltd. Announce Shareholders Approval of Merger

On October 23rd, at the EGM of shareholders, the merger agreement between Celltrion, Inc. & Celltrion Healthcare Co., Ltd. was approved Celltrion Group’s board of...

Alphawave Semi Announces Appointment of Rahul Mathur as Chief Financial Officer

Addition of experienced semiconductor CFO drives the next phase of business growth to create leading-edge AI infrastructure LONDON & TORONTO–(BUSINESS WIRE)– Alphawave IP Group plc...

EH Group tests HTPEM Fuel Cell to decarbonise aviation

NYON, Switzerland–(BUSINESS WIRE)– EH Group has successfully tested its unique fuel cell technology in high temperature PEM mode (HTPEMFC). The proprietary structure of EH Group’s...

ENHERTU® Approved in the EU as the First HER2 Directed Therapy for Patients with HER2 Mutant Advanced Non-Small Cell Lung Cancer

Approval based on DESTINY-Lung02 trial results where Daiichi Sankyo and AstraZeneca’s ENHERTU demonstrated a confirmed objective response rate of 49.0% and median duration of response...

Gegevens gepresenteerd tijdens de UEG Week 2023 onderstrepen het potentieel van subcutaan infliximab CT-P13 SC, een onderzoeksgeneesmiddel van Celltrion voor de behandeling van inflammatoire darmziekte

De nieuwste gegevens uit klinische onderzoeken naar subcutane (SC) infliximab (CT-P13 SC), gepresenteerd tijdens de United European Gastroenterology Week 2023 (UEG Week 2023) in Kopenhagen,...

Celltrion USA Announces U.S. FDA Approval of ZYMFENTRA® (infliximab-dyyb), the First and Only Subcutaneous infliximab, for the Treatment of People With Inflammatory Bowel Disease

ZYMFENTRA® is the first and only FDA-approved subcutaneous (SC) formulation of infliximab approved for the maintenance treatment of adult patients with moderately to severely active...

Aviapartner breidt haar armslag uit via een joint venture met Zuid-Afrika

BRUSSEL–(BUSINESS WIRE)– Aviapartner, de vooraanstaande Airport Ground Services-groep van Europa, sluit een joint venture met Colossal om luchtvaartmaatschappijen en passagiers in Zuid-Afrika te dienen. Via...